Show simple item record

dc.contributor.authorWarrenfeltz, Susanne
dc.contributor.authorPavlik, Stephen
dc.contributor.authorDatta, Susmita
dc.contributor.authorKraemer, Eileen T
dc.contributor.authorBenigno, Benedict
dc.contributor.authorMcDonald, John F
dc.date.accessioned2013-06-12T15:26:39Z
dc.date.available2013-06-12T15:26:39Z
dc.date.issued2004-10-07
dc.identifier.citationMolecular Cancer. 2004 Oct 07;3(1):27
dc.identifier.urihttp://dx.doi.org/10.1186/1476-4598-3-27
dc.identifier.urihttp://hdl.handle.net/10724/19814
dc.description.abstractAbstract Background Epithelial ovarian tumours exhibit a range of malignant potential, presenting distinct clinical phenotypes. Improved knowledge of gene expression changes and functional pathways associated with these clinical phenotypes may lead to new treatment targets, markers for early detection and a better understanding of disease progression. Results Gene expression profiling (Affymetrix, U95Av2) was carried out on 18 ovarian tumours including benign adenomas, borderline adenocarcinomas of low malignant potential and malignant adenocarcinomas. Clustering the expression profiles of samples from patients not treated with chemotherapy prior to surgery effectively classified 92% of samples into their proper histopathological group. Some cancer samples from patients treated with chemotherapy prior to surgery clustered with the benign adenomas. Chemotherapy patients whose tumours exhibited benign-like expression patterns remained disease free for the duration of this study as indicated by continued normal serum CA-125 levels. Statistical analysis identified 163 differentially expressed genes: 61 genes under-expressed in cancer and 102 genes over-expressed in cancer. Profiling the functional categories of co-ordinately expressed genes within this list revealed significant correlation between increased malignant potential and loss of both IGF binding proteins and cell adhesion molecules. Interestingly, in several instances co-ordinately expressed genes sharing biological function also shared chromosomal location. Conclusion Our findings indicate that gene expression profiling can reliably distinguish between benign and malignant ovarian tumours. Expression profiles of samples from patients pre-treated with chemotherapy may be useful in predicting disease free survival and the likelihood of recurrence. Loss of expression of IGF binding proteins as well as specific cell adhesion molecules may be a significant mechanism of disease progression in ovarian cancer. Expression levels in borderline tumours were intermediate between benign adenomas and malignant adenocarcinomas for a significant portion of the differentially expressed genes, suggesting that borderline tumours are a transitional state between benign and malignant tumours. Finally, genes displaying coordinated changes in gene expression were often genetically linked, suggesting that changes in expression for these genes are the consequence of regional duplications, deletions or epigenetic events.
dc.titleGene expression profiling of epithelial ovarian tumours correlated with malignant potential
dc.typeJournal Article
dc.date.updated2013-06-07T19:55:33Z
dc.description.versionPeer Reviewed
dc.language.rfc3066en
dc.rights.holderSusanne Warrenfeltz et al.; licensee BioMed Central Ltd.


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record